{
    "Rank": 890,
    "Study": {
        "ProtocolSection": {
            "IdentificationModule": {
                "NCTId": "NCT00898274",
                "OrgStudyIdInfo": {
                    "OrgStudyId": "CASE11807"
                },
                "SecondaryIdInfoList": {
                    "SecondaryIdInfo": [
                        {
                            "SecondaryId": "P30CA043703",
                            "SecondaryIdType": "U.S. NIH Grant/Contract",
                            "SecondaryIdLink": "https://reporter.nih.gov/quickSearch/P30CA043703"
                        },
                        {
                            "SecondaryId": "CASE11807",
                            "SecondaryIdType": "Other Identifier",
                            "SecondaryIdDomain": "Case Comprehensive Cancer Center"
                        }
                    ]
                },
                "Organization": {
                    "OrgFullName": "Case Comprehensive Cancer Center",
                    "OrgClass": "OTHER"
                },
                "BriefTitle": "Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male Participants",
                "OfficialTitle": "Antioxidant Enzymes and Oxidative DNA Damage in Subjects With 'High-Risk' for Prostate Cancer"
            },
            "StatusModule": {
                "StatusVerifiedDate": "March 2016",
                "OverallStatus": "Completed",
                "ExpandedAccessInfo": {
                    "HasExpandedAccess": "No"
                },
                "StartDateStruct": {
                    "StartDate": "January 2008"
                },
                "PrimaryCompletionDateStruct": {
                    "PrimaryCompletionDate": "May 2011",
                    "PrimaryCompletionDateType": "Actual"
                },
                "CompletionDateStruct": {
                    "CompletionDate": "May 2011",
                    "CompletionDateType": "Actual"
                },
                "StudyFirstSubmitDate": "May 9, 2009",
                "StudyFirstSubmitQCDate": "May 9, 2009",
                "StudyFirstPostDateStruct": {
                    "StudyFirstPostDate": "May 12, 2009",
                    "StudyFirstPostDateType": "Estimate"
                },
                "LastUpdateSubmitDate": "March 8, 2016",
                "LastUpdatePostDateStruct": {
                    "LastUpdatePostDate": "March 9, 2016",
                    "LastUpdatePostDateType": "Estimate"
                }
            },
            "SponsorCollaboratorsModule": {
                "ResponsibleParty": {
                    "ResponsiblePartyType": "Sponsor"
                },
                "LeadSponsor": {
                    "LeadSponsorName": "Case Comprehensive Cancer Center",
                    "LeadSponsorClass": "OTHER"
                },
                "CollaboratorList": {
                    "Collaborator": [
                        {
                            "CollaboratorName": "National Cancer Institute (NCI)",
                            "CollaboratorClass": "NIH"
                        }
                    ]
                }
            },
            "OversightModule": {
                "OversightHasDMC": "Yes"
            },
            "DescriptionModule": {
                "BriefSummary": "RATIONALE: Studying samples of blood in the laboratory from patients who are at high risk of developing prostate cancer may help doctors identify biomarkers related to cancer.\n\nPURPOSE: This research study is looking at blood samples from patients at high risk of developing prostate cancer and from healthy male participants.",
                "DetailedDescription": "OBJECTIVES:\n\nTo determine whether there are any changes in pro-oxidant-antioxidant profiles in patients who are at high risk for developing prostate cancer.\nTo compare the profiles of these patients with those of healthy controls.\n\nOUTLINE: Participants undergo blood sample collection. Samples are used to measure levels of antioxidant enzymes (i.e., glutathione, glutathione peroxidase, glutathione reductase, superoxide dismutase, and reduced glutathione) and biomarkers of oxidative stress and DNA damage in leukocytes (i.e., thiobarbituric acid reactive substances [TBARS] and 8-hydroxydeoxyguanosine). Samples are analyzed via antioxidant enzyme assay, TBARS assay, and enzyme-linked immunosorbent assay.\n\nPROJECTED ACCRUAL: A total of 40 participants (20 at high risk for developing prostate cancer and 20 healthy controls) will be accrued for this study."
            },
            "ConditionsModule": {
                "ConditionList": {
                    "Condition": [
                        "Precancerous Condition",
                        "Prostate Cancer"
                    ]
                },
                "KeywordList": {
                    "Keyword": [
                        "prostate cancer",
                        "high grade prostatic intraepithelial neoplasia"
                    ]
                }
            },
            "DesignModule": {
                "StudyType": "Observational",
                "DesignInfo": {
                    "DesignObservationalModelList": {
                        "DesignObservationalModel": [
                            "Case-Control"
                        ]
                    },
                    "DesignTimePerspectiveList": {
                        "DesignTimePerspective": [
                            "Prospective"
                        ]
                    }
                },
                "BioSpec": {
                    "BioSpecRetention": "Samples With DNA",
                    "BioSpecDescription": "Blood samples from patients at high risk of developing prostate cancer and from healthy male participants."
                },
                "EnrollmentInfo": {
                    "EnrollmentCount": "40",
                    "EnrollmentType": "Actual"
                }
            },
            "ArmsInterventionsModule": {
                "ArmGroupList": {
                    "ArmGroup": [
                        {
                            "ArmGroupLabel": "High risk for developing prostate cancer",
                            "ArmGroupDescription": "Male subjects age 45-65 at high risk for developing prostate cancer.",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Other: immunoenzyme technique",
                                    "Other: laboratory biomarker analysis"
                                ]
                            }
                        },
                        {
                            "ArmGroupLabel": "Healthy participants",
                            "ArmGroupDescription": "Aged matched healthy participants",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Other: immunoenzyme technique",
                                    "Other: laboratory biomarker analysis"
                                ]
                            }
                        }
                    ]
                },
                "InterventionList": {
                    "Intervention": [
                        {
                            "InterventionType": "Other",
                            "InterventionName": "immunoenzyme technique",
                            "InterventionDescription": "Participants undergo blood sample collection. Samples are used to measure levels of antioxidant enzymes (i.e., glutathione, glutathione peroxidase, glutathione reductase, superoxide dismutase, and reduced glutathione) and biomarkers of oxidative stress and DNA damage in leukocytes (i.e., thiobarbituric acid reactive substances [TBARS] and 8-hydroxydeoxyguanosine). Samples are analyzed via antioxidant enzyme assay, TBARS assay, and enzyme-linked immunosorbent assay.",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Healthy participants",
                                    "High risk for developing prostate cancer"
                                ]
                            }
                        },
                        {
                            "InterventionType": "Other",
                            "InterventionName": "laboratory biomarker analysis",
                            "InterventionDescription": "Participants undergo blood sample collection. Samples are used to measure levels of antioxidant enzymes (i.e., glutathione, glutathione peroxidase, glutathione reductase, superoxide dismutase, and reduced glutathione) and biomarkers of oxidative stress and DNA damage in leukocytes (i.e., thiobarbituric acid reactive substances [TBARS] and 8-hydroxydeoxyguanosine). Samples are analyzed via antioxidant enzyme assay, TBARS assay, and enzyme-linked immunosorbent assay.",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Healthy participants",
                                    "High risk for developing prostate cancer"
                                ]
                            }
                        }
                    ]
                }
            },
            "OutcomesModule": {
                "PrimaryOutcomeList": {
                    "PrimaryOutcome": [
                        {
                            "PrimaryOutcomeMeasure": "Plasma levels of antioxidant enzymes as assessed by antioxidant enzyme assay, TBARS assay, and enzyme-linked immunosorbent assay",
                            "PrimaryOutcomeDescription": "Blood (5ml) will be drawn from subjects for use in the various assays.",
                            "PrimaryOutcomeTimeFrame": "at time of study entry"
                        },
                        {
                            "PrimaryOutcomeMeasure": "Oxidative DNA damage as assessed by antioxidant enzyme assay, TBARS assay, and enzyme-linked immunosorbent assay",
                            "PrimaryOutcomeDescription": "Blood (5ml) will be drawn from subjects for use in the various assays.",
                            "PrimaryOutcomeTimeFrame": "at time of study entry"
                        }
                    ]
                }
            },
            "EligibilityModule": {
                "EligibilityCriteria": "DISEASE CHARACTERISTICS:\n\nMeets 1 of the following criteria:\n\nPatient at high risk for developing prostate cancer, due to 1 of the following risk factors:\n\nHistologically confirmed proliferative inflammatory atrophy and/or high-grade prostatic intraepithelial neoplasia lesions accompanied by chronic intraprostatic inflammation\nAbnormality observed during digital rectal exam or transrectal ultrasonography\n\nContinued elevated age-adjusted prostate-specific antigen (PSA) meeting at least 1 of the following criteria:\n\nScreening PSA > 4.0 ng/mL\nFree PSA < 18%\nPSA velocity > 0.75 ng/mL within the past year\n\nHealthy volunteer meeting the following criteria:\n\nAge-matched\nNormal PSA level (\u2264 2.1 ng/mL)\nNormal digital rectal exam\nNo prostatitis or benign prostate hyperplasia\nNo urinary symptoms (diagnosed or undiagnosed)\nNo diagnosis of cancer\n\nPATIENT CHARACTERISTICS:\n\nPatients and healthy controls:\n\nNo chronic inflammatory conditions, especially those for which regular use of non-steroidal anti-inflammatory medications (NSAIDs) is prescribed/recommended, including any of the following:\n\nCoronary heart disease\nChronic obstructive pulmonary disease (COPD)\nPsoriasis\nPelvic inflammatory disease\nMultiple sclerosis\nArthritis\nLupus\nHashimoto thyroiditis\nInflammatory bowel disease (i.e., ulcerative colitis or Crohn disease)\n\nPRIOR CONCURRENT THERAPY:\n\nNo prior radiotherapy or surgery to the prostate (healthy controls)",
                "HealthyVolunteers": "Accepts Healthy Volunteers",
                "Gender": "Male",
                "MinimumAge": "45 Years",
                "MaximumAge": "65 Years",
                "StdAgeList": {
                    "StdAge": [
                        "Adult",
                        "Older Adult"
                    ]
                },
                "StudyPopulation": "Primary Care Clinic",
                "SamplingMethod": "Probability Sample"
            },
            "ContactsLocationsModule": {
                "OverallOfficialList": {
                    "OverallOfficial": [
                        {
                            "OverallOfficialName": "Sanjay Gupta, PhD",
                            "OverallOfficialAffiliation": "Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center",
                            "OverallOfficialRole": "Study Chair"
                        }
                    ]
                },
                "LocationList": {
                    "Location": [
                        {
                            "LocationFacility": "Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center",
                            "LocationCity": "Cleveland",
                            "LocationState": "Ohio",
                            "LocationZip": "44106-5065",
                            "LocationCountry": "United States"
                        },
                        {
                            "LocationFacility": "University Suburban Health Center",
                            "LocationCity": "Cleveland",
                            "LocationState": "Ohio",
                            "LocationZip": "44121",
                            "LocationCountry": "United States"
                        },
                        {
                            "LocationFacility": "UHHS Chagrin Highlands Medical Center",
                            "LocationCity": "Cleveland",
                            "LocationState": "Ohio",
                            "LocationZip": "44122",
                            "LocationCountry": "United States"
                        }
                    ]
                }
            }
        },
        "DerivedSection": {
            "MiscInfoModule": {
                "VersionHolder": "September 08, 2023"
            },
            "ConditionBrowseModule": {
                "ConditionMeshList": {
                    "ConditionMesh": [
                        {
                            "ConditionMeshId": "D000011471",
                            "ConditionMeshTerm": "Prostatic Neoplasms"
                        },
                        {
                            "ConditionMeshId": "D000011230",
                            "ConditionMeshTerm": "Precancerous Conditions"
                        }
                    ]
                },
                "ConditionAncestorList": {
                    "ConditionAncestor": [
                        {
                            "ConditionAncestorId": "D000005834",
                            "ConditionAncestorTerm": "Genital Neoplasms, Male"
                        },
                        {
                            "ConditionAncestorId": "D000014565",
                            "ConditionAncestorTerm": "Urogenital Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000009371",
                            "ConditionAncestorTerm": "Neoplasms by Site"
                        },
                        {
                            "ConditionAncestorId": "D000009369",
                            "ConditionAncestorTerm": "Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000005832",
                            "ConditionAncestorTerm": "Genital Diseases, Male"
                        },
                        {
                            "ConditionAncestorId": "D000091662",
                            "ConditionAncestorTerm": "Genital Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000091642",
                            "ConditionAncestorTerm": "Urogenital Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000011469",
                            "ConditionAncestorTerm": "Prostatic Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000052801",
                            "ConditionAncestorTerm": "Male Urogenital Diseases"
                        }
                    ]
                },
                "ConditionBrowseLeafList": {
                    "ConditionBrowseLeaf": [
                        {
                            "ConditionBrowseLeafId": "M14025",
                            "ConditionBrowseLeafName": "Prostatic Neoplasms",
                            "ConditionBrowseLeafAsFound": "Prostate Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M13801",
                            "ConditionBrowseLeafName": "Precancerous Conditions",
                            "ConditionBrowseLeafAsFound": "Precancerous Condition",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M20762",
                            "ConditionBrowseLeafName": "Prostatic Intraepithelial Neoplasia",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M8636",
                            "ConditionBrowseLeafName": "Genital Neoplasms, Male",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M17005",
                            "ConditionBrowseLeafName": "Urogenital Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M2877",
                            "ConditionBrowseLeafName": "Genital Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M8634",
                            "ConditionBrowseLeafName": "Genital Diseases, Male",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M2876",
                            "ConditionBrowseLeafName": "Urogenital Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M14023",
                            "ConditionBrowseLeafName": "Prostatic Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M26785",
                            "ConditionBrowseLeafName": "Male Urogenital Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "ConditionBrowseBranchList": {
                    "ConditionBrowseBranch": [
                        {
                            "ConditionBrowseBranchAbbrev": "BC04",
                            "ConditionBrowseBranchName": "Neoplasms"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BXS",
                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "All",
                            "ConditionBrowseBranchName": "All Conditions"
                        }
                    ]
                }
            },
            "InterventionBrowseModule": {
                "InterventionBrowseLeafList": {
                    "InterventionBrowseLeaf": [
                        {
                            "InterventionBrowseLeafId": "M3982",
                            "InterventionBrowseLeafName": "Antioxidants",
                            "InterventionBrowseLeafRelevance": "low"
                        },
                        {
                            "InterventionBrowseLeafId": "M15954",
                            "InterventionBrowseLeafName": "Superoxide Dismutase",
                            "InterventionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "InterventionBrowseBranchList": {
                    "InterventionBrowseBranch": [
                        {
                            "InterventionBrowseBranchAbbrev": "All",
                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                        }
                    ]
                }
            }
        }
    }
}